MSH2 and cancer: In addition to impairing spermatogenesis, mutations in the BRCA2, CHEK2, ATM, TP53, RB1, and MMR genes (MLH1, MSH2, MSH6, PMS2) significantly increase the risk of developing cancer [88,89].